192 related articles for article (PubMed ID: 18451802)
21. Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis.
Pratama E; Tian X; Lestari W; Iseki S; Ichwan SJ; Ikeda MA
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):248-54. PubMed ID: 26519881
[TBL] [Abstract][Full Text] [Related]
22. By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer.
Zhang Q; Song Y; Chen W; Wang X; Miao Z; Cao L; Li F; Wang G
Oncotarget; 2015 Jun; 6(18):16461-70. PubMed ID: 26098774
[TBL] [Abstract][Full Text] [Related]
23. GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation.
Park JH; Roeder RG
Mol Cell Biol; 2006 Jun; 26(11):4006-16. PubMed ID: 16705155
[TBL] [Abstract][Full Text] [Related]
24. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
25. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
[TBL] [Abstract][Full Text] [Related]
26. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
27. Repression of p53-mediated transcription by adenovirus E1B 55-kDa does not require corepressor mSin3A and histone deacetylases.
Zhao LY; Santiago A; Liu J; Liao D
J Biol Chem; 2007 Mar; 282(10):7001-10. PubMed ID: 17209038
[TBL] [Abstract][Full Text] [Related]
28. p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A.
Tanikawa J; Nomura T; Macmillan EM; Shinagawa T; Jin W; Kokura K; Baba D; Shirakawa M; Gonda TJ; Ishii S
J Biol Chem; 2004 Dec; 279(53):55393-400. PubMed ID: 15509555
[TBL] [Abstract][Full Text] [Related]
29. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
[TBL] [Abstract][Full Text] [Related]
30. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
[TBL] [Abstract][Full Text] [Related]
31. The transcription factor p53: not a repressor, solely an activator.
Fischer M; Steiner L; Engeland K
Cell Cycle; 2014; 13(19):3037-58. PubMed ID: 25486564
[TBL] [Abstract][Full Text] [Related]
32. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.
Uxa S; Bernhart SH; Mages CFS; Fischer M; Kohler R; Hoffmann S; Stadler PF; Engeland K; Müller GA
Nucleic Acids Res; 2019 Sep; 47(17):9087-9103. PubMed ID: 31400114
[TBL] [Abstract][Full Text] [Related]
33. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
[TBL] [Abstract][Full Text] [Related]
34. p130/E2F4 binds to and represses the cdc2 promoter in response to p53.
Taylor WR; Schonthal AH; Galante J; Stark GR
J Biol Chem; 2001 Jan; 276(3):1998-2006. PubMed ID: 11032828
[TBL] [Abstract][Full Text] [Related]
35. A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.
Hou X; Liu JE; Liu W; Liu CY; Liu ZY; Sun ZY
Oncogene; 2011 Jun; 30(26):2933-42. PubMed ID: 21317932
[TBL] [Abstract][Full Text] [Related]
36. p53 Binding to the p21 promoter is dependent on the nature of DNA damage.
Hill R; Bodzak E; Blough MD; Lee PW
Cell Cycle; 2008 Aug; 7(16):2535-43. PubMed ID: 18719376
[TBL] [Abstract][Full Text] [Related]
37. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
Hoffman WH; Biade S; Zilfou JT; Chen J; Murphy M
J Biol Chem; 2002 Feb; 277(5):3247-57. PubMed ID: 11714700
[TBL] [Abstract][Full Text] [Related]
39. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
40. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
